NIH Grant Reviews Don’t Predict Success

Peer reviewers’ assessments of funding proposals to the National Institutes of Health don’t correlate well with later publication citations, a study shows.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, QUINN DOMBROWSKIJudgments made by peer reviewers about the merit of grant proposals submitted to the National Institutes of Health (NIH) aren’t predictive of the subsequent productivity of the research. That’s the conclusion of a recent study, published in eLife February 16, which analyzed the number of citations and publications resulting from funded projects.

“The excellent productivity exhibited by many projects with relatively poor scores and the poor productivity exhibited by some projects with outstanding scores demonstrate the inherent unpredictability of scientific research,” Ferric Fang of the University of Washington School of Medicine and coauthors wrote in their report.

Studies on the predictive power of peer-review panels have yielded a mixed bag of results—some show they are not very good at deciding which projects will be the most productive. Yet a recent review of more than 130,000 grant proposals found that peer reviewers’ high scores correlated well with research projects that would end up with the most publications, citations, and patents.

That study included all proposals (both the high- and low-ranked), but Fang’s team wanted to look only at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies